Literature DB >> 20671411

Diagnostic and therapeutic challenge in the management of a patient with ectopic adrenocorticotropin secretion.

F Sanguin, N Albiger, C Betterle, C Mian, R Gatti, E Rossi, F Mantero, C Scaroni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20671411     DOI： 10.1007/BF03346634

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?

Authors:  G I Uwaifo; C A Koch; B Hirshberg; C C Chen; P Hartzband; L K Nieman; K Pacak
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

2.  Merits and pitfalls of mifepristone in Cushing's syndrome.

Authors:  F Castinetti; M Fassnacht; S Johanssen; M Terzolo; P Bouchard; P Chanson; C Do Cao; I Morange; A Picó; S Ouzounian; J Young; S Hahner; T Brue; B Allolio; B Conte-Devolx
Journal:  Eur J Endocrinol       Date:  2009-03-16       Impact factor: 6.664

Review 3.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

Review 4.  Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.

Authors:  C de Bruin; R A Feelders; S W J Lamberts; L J Hofland
Journal:  Rev Endocr Metab Disord       Date:  2008-07-19       Impact factor: 6.514

5.  Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

Authors:  I Buchmann; M Henze; S Engelbrecht; M Eisenhut; A Runz; M Schäfer; T Schilling; S Haufe; T Herrmann; U Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-23       Impact factor: 9.236
  5 in total
  1 in total

1.  Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature.

Authors:  Da Zhang; Lin Lu; Hui-Juan Zhu; Yu Xiao; Xian-Lin Han; Shun-Da Du; Hua-Dan Xue; Qing-Xing Liu; Zhao-Hui Zhu; Ming-Ming Hu; Xiao Zhai; Xiao-Ping Xing; Zhao-Lin Lu
Journal:  Int J Endocrinol       Date:  2022-02-28       Impact factor: 3.257
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.